Patients with conditions characterized by chronic inflammation, such as cardiovascular disease, metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), or metabolic syndrome, should discuss how tirzepatide fits into their comprehensive management plan
[3] [4] Signs and symptoms [edit] Withdrawal symptoms occur during dose reduction and may include insomnia, anxiety, distress, weight loss, dizziness, night sweats, shaking, muscle twitches, aphasia, panic attacks, depression, numbness, dissociation, paranoia, indigestion, diarrhea, and photophobia
Acknowledgements This insight article was supported by the National Natural Science Foundation of China (81901107) and the China Postdoctoral Science Foundation (2018M632872)
Suppression of normally occurring reactive astrogliosis worsens neurological outcome and inhibits postlesional plasticity, regeneration and repair, as well as a restoration of the blood-brain barrier, which all determine functional tissue remodelling and post-traumatic rehabilitation
10.1007/s10072-014-1657-0 Neurol
They recommend exercise, tai chi, and self-efficacy or self-management programs
